Diagnostics; making a difference

Member Press Releases

Current Articles | Categories | Search | Syndication

02 February 2016  
Faecal Immunochemical Testing (FIT) is Cost Effective Compared to Colonoscopy
By @ 10:09 :: 16 Views



The new NICE guidelines [NG12] for “Suspected cancer: recognition and referral” have recommended Faecal Occult Blood Testing (FOBT) as a cost effective method in primary care, for detecting colorectal cancers in people aged 40 or older with a change in bowel habit.
Laboratories who embrace the newer technology of qFIT can provide a more proactive service to their community whilst enjoying the productivity benefits of an automated system such as
HM-JACKarc from Alpha Laboratories.
The NICE publication reverses the original decision from 2004, to cease guaiac based testing, which has resulted in a significant decline in FOBT since then. 

Read More

18 January 2016  
Atomo Secures US$6M from the Global Health Investment Fund
By @ 09:23 :: 63 Views


Atomo Secures US$6M Investment From GHIF_140116

The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance

Read More

12 January 2016  
Beckman Coulter Diagnostics DxN VERIS Molecular Diagnostics System: Proven to be Easy to Learn and Operate
By @ 12:42 :: 80 Views


Sheffield Teaching Hospitals NHS Trust report ease of use

 

Nyon, Switzerland — (12 January 2016) Beckman Coulter recently commissioned independent system performance trials of the new DxN VERIS Molecular Diagnostics System* and results show that the system is easy to operate with technicians fully operational on the system following just 20 minutes training.

 

Read More

12 January 2016  
New Alpha Laboratories Website Designed and Built to Meet Scientists' Needs
By @ 12:31 :: 89 Views


Following a customer survey, the Alpha Laboratories website has now been completely re-developed and launched on an advanced, fully responsive e-commerce platform. The modern design and functionality incorporates many of the suggestions received from users, to bring a much easier, more informative and enjoyable online experience. See it now, live at www.alphalabs.co.uk  . 
Read More

03 December 2015  
Beckman Coulter Diagnostics Unveils Its Molecular Diagnostics Website
By @ 12:13 :: 191 Views :: 2015


Nyon, Switzerland — (03 December 2015) Beckman Coulter Diagnostics today launched its new website specifically for molecular diagnostics.  The new site beckmancoulter.com/moleculardiagnostics has been designed not only to showcase the company’s DxN VERIS Molecular Diagnostics System* but also to provide quick and easy access to scientific resources and educational materials for the molecular diagnostics laboratory.

 

Read More

23 November 2015  
Randox Laboratories and Biosytems International announce completion of clinical trial and licencing for QuantiPlasmaTM antibodies for early lung cancer diagnostics
By @ 16:51 :: 188 Views :: 2015


CRUMLIN, NORTHERN IRELAND / DEBRECEN, HUNGARY

Read More

18 November 2015  
New Ownership to Fuel Further Growth and Innovation at BBI Group
By @ 12:22 :: 206 Views :: 2015

 

18th November 2015 - CARDIFF, U.K. – The BBI Group (BBI), a trusted partner to many of the world’s leading diagnostic and healthcare organisations, today announced the completion of the acquisition by Exponent Private Equity.

Read More

17 November 2015  
Beckman Coulter Diagnostics DxN VERIS Molecular Diagnostic System Consolidates Workload and Improves Productivity
By @ 15:50 :: 200 Views :: 2015



Spanish study now available

Nyon, Switzerland — (17 November 2015) Beckman Coulter Diagnostics today announced the availability of an independent case study, undertaken in Spain, that demonstrates that the company’s DxN VERIS  Molecular Diagnostics System* has the potential to improve productivity and turnaround times.

Read More

16 November 2015  
UroSens Announces Corporate Name Change and Rebranding to Arquer Diagnostics Ltd
By @ 14:18 :: 224 Views :: 2015

 

                   Rebranding reflects Company’s expansion into new oncology areas

Sunderland and Cambridge, UK, 20 July 2015:
UroSens Ltd, a diagnostic company developing novel, non-invasive urine-based immunoassay tests for the detection of cancer, has announced it has changed its name to Arquer Diagnostics Ltd (Arquer). As part of the name change, the Company has undergone a total brand refresh, which will see the implementation of a new visual identity and online presence to support Arquer’s future plans, evolution and growth, with immediate effect. To coincide with the rebranding, Arquer has launched a redesigned website http://www.arquerdx.com/

Read More

06 November 2015  
Serum Indices Quality Controls available exclusively from Cambridge Life Sciences Ltd
By @ 17:03 :: 256 Views :: 2015

As part of an exclusive distribution deal with Advance Diagnostic Products, Cambridge Life Sciences, is proud to offer Serum Indices Quality Controls which can routinely check the indices scanning performance of automated analysers

Read More

Previous Page | Next Page